In This Section
AIPLA 2021 Annual Meeting On-Demand!
May 28 to August 1, 2022
Location
Virtual
On-Demand
Credits
Virtual Attendees can receive 1,140 CLE minutes, including 90 minutes of Ethics for the on-demand sessions.
Registration
Fee: Fee: Members: $395; Non Members: $795
Register Now
AIPLA's 2021 Annual Meeting is now available on-demand.
Topics include:
- Patent Prosecution - Patenting Computer-Implemented Inventions and AI and Issues Facing Innovators in Life Sciences
- Copyright - A Deep Dive into the DMCA
- Trademark - Managing Your Brand in Times of Social Change and the Interplay of Failure to Function as a Mark and Aesthetic Functionality
- Analyzing the Oracle v. Google Decision
- Patents & Diversity: Expanding Economic Opportunity Through Innovation
- An Update on the PTAB
- Patent Exhaustion and It's Impact on Claims Strategy
- IP Litigation including IP Injunctions and Appellate Mishaps
- Corporate Practice - Drafting Agreements and Licenses and also Cultural Competence and Mental Health, Ethics, and Being a Leader Through a Crisis.
- Ethics in Trade Secret Cases
- Antitrust Issues in IP Scenarios
Click here to purchase!
Virtual Attendees can receive 1,140 CLE minutes, including 90 minutes of Ethics for the on-demand sessions. To receive credit, attendees must complete a Session Evaluation Survey for each session. Session Evaluation Surveys can be found under the Resources section of each session page. Surveys must be completed within 3 days of watching an event.
Click here to view the Full Program!
Schedule
Thursday, October 28
9 - 10 am - Opening Plenary
10:15 am - Noon - Concurrent Tracks
2:15 - 3:45 pm - Concurrent Tracks
Friday, October 29
9 - 10 am - Concurrent Tracks
10:15 am - Noon - Concurrent Tracks
2:15 - 3:45 pm - Concurrent Tracks
Saturday, October 30
9 am - Noon - Closing Plenary: Year in Review
News
-
AIPLA Submits Comments to EPO on 2022 Revised Guidelines for Examination
May 13, 2022
On April 8, AIPLA Submitted comments to the European Patent Office (EPO) on their revised 2022 Guidelines for Examination. AIPLA welcomes the current effort of the EPO to collect comments from stakeholders regarding changes to said Guidelines. We hope that our views will assist the EPO in its process of revising its Guidelines to benefit all stakeholders rather than place unnecessary burdens on them. -
JOINT STATEMENT ON TENTATIVE TRIPS WAIVER COMPROMISE
March 28, 2022
On March 24, AIPLA, along with the Intellectual Property Owners Association (IPO), Licensing Executives Society International (LESI), Licensing Executives Society USA & Canada, and the New York Intellectual Property Law Association (NYIPLA) issued a joint statement on the tentative TRIPs Waiver Compromise. -
AIPLA Submits Comments to the USPTO Notice of the Deferred Subject Matter Eligibility Response Pilot Program.
March 8, 2022
On March 7, AIPLA submitted comments on the recent USPTO Notice of the Deferred Subject Matter Eligibility Response Pilot Program. AIPLA provided a number of suggestions for the Office's consideration on improvements or clarifications to the pilot program. -
Supreme Court Vacated and Remanded the Ninth Circuit’s decision in Unicolors, Inc. v. H&M Hennes and Mauritz, LP
February 24, 2022
On February 24, 2022 the U.S. Supreme Court Vacated and Remanded the Ninth Circuit’s decision in Unicolors, Inc. v. H&M Hennes and Mauritz, LP. This ruling is consistent with the amicus brief filed by AIPLA on August 10, 2021. -
AIPLA Submits Comments to US Copyright Office Pursuant to Notice of Proposed Rulemaking: Copyright Claims Board - Active Proceedings and Evidence
February 10, 2022
On February 7, 2022, AIPLA submitted comments in response to the U.S. Copyright Office Notice of Proposed Rulemaking related to practice procedures before the Copyright Claims Board. AIPLA noted that the success of the CASE Act will turn in significant part on the simplicity and accessibility of the trial procedures. We commended the Office for its efforts to develop user-friendly Copyright Claims Board (“CCB”) procedures. AIPLA offered responses and comments to certain of the questions and rules raised by the Office in the Notice with regard to the management of parties; the management of the proceedings; discovery; evidence; hearings; and, post-determination proceedings.